SEARCH

SEARCH BY CITATION

References

  • 1
    Penn I . Occurrence of cancers in immunosuppressed organ transplant recipients . Clin Transpl 1998a ; 10 : 147158 .
  • 2
    Morrison VA , Dunn DL , Manivel JC et al. Clinical characteristics of post-transplant lymphoproliferative disorders . Am J Med 1994 ; 97 : 1424 .
  • 3
    Nalesnik MA . Clinicopathologic characteristics of post-transplant lymphoproliferative disorders . Recent Results Cancer Res 2002 ; 159 : 918 .
  • 4
    Penn I . Cancers in cyclosporine-treated vs azathioprine-treated patients . Transpl Proc 1996 ; 28 : 876878 .
  • 5
    Penn I . De novo malignancies in pediatric organ transplant recipients . Pediatr Transplant 1998b ; 2 : 5663 .
  • 6
    Opelz G , Henderson R . Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients . Lancet 1993 ; 342 : 15141516 .
  • 7
    Penn I . Cancers following cyclosporine therapy . Transpl Proc 1987 ; 19 : 22112213 .
  • 8
    Sheil AGR , Disney APS , Mathew TH , Livingston BER , Keogh AM . Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation . Transpl Proc 1997 ; 29 : 825827 .
  • 9
    Opelz G , Schwarz V , Henderson R , Kneifel G , Ruhenstroth A . Non-Hodgkin lymphoma after kidney or heart transplantation: frequency of occurrence during the first posttransplant year . Transpl Int 1994 ; 7 : S353S356 .
  • 10
    Shapiro R , Nalesnik M , McCauley J et al. Posttransplant lymphoproliferative disorder in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression . Transplantation 1999 ; 68 : 18511854 .
  • 11
    Dharnidharka VR , Sullivan EK , Stablein DM , Tejani AH , Harmon WE . Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American pediatric renal Transplant Cooperative Study (NAPRTCS) . Transplantation 2001 ; 71 : 10651068 .
  • 12
    Swinnen LJ , Costanzo-Nordin MR , Fisher SG et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients . N Engl J Med 1990 ; 323 : 17231728 .
  • 13
    Melosky B , Karim M , Chui A et al. Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression . J Am Soc Nephrol 1992 ; 2 : S290S294 .
  • 14
    Wilkinson AH , Smith JL , Hunsicker LG et al. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone . Transplantation 1989 ; 21 : 31993200 .
  • 15
    Nalesnik MA , Makowska L , Starzl T . The diagnosis and treatment of posttransplant lymphoproliferative disorders . Curr Probl Surg 1988 ; 25 : 371472 .
  • 16
    Hanto DW , Frizzera G , Gajl-Preczalska KJ , Simmons RL . Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation . Transplantation 1985 ; 39 : 461472 .
  • 17
    Birkeland SA . Chronic antigenic stimulation from the graft as a possible oncogenic factor after renal transplantation . Scand J Urol Nephrol 1983 ; 17 : 355359 .
  • 18
    Lim GY , Newman B , Kurland G , Webber SA . Posttransplantation lymphoproliferative disorder: manifestations in pediatric thoracic organ recipients . Radiology 2002 ; 222 : 699708 .
  • 19
    Donnelly LF , Frush DP , Marshall KW , White KS . Lymphoproliferative disorders: CT findings in immunocompromised children . AJR 1998 ; 171 : 725731 .
  • 20
    Starzl T , Porter KA , Iwatsuki S et al. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporine-steroid therapy . Lancet 1984 ; 1 : 583587 .
  • 21
    Swinnen LJ . Organ transplant-related lymphoma . Curr Treat Options Oncol 2001 ; 2 : 301308 .
  • 22
    Armitage JM , Kormos RL , Stuart RS et al. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression . J Heart Lung Transpl 1991 ; 10 : 877887 .
  • 23
    Dotti G , Fiocchi R , Motta T et al. Epstein-Barr virus-negative lymphoproliferative disorders in long-term survivors after heart, kidney, and liver transplant . Transplantation 2000 ; 69 : 827833 .
  • 24
    Hayashi RJ , Kraus MD , Patel AL et al. Posttransplant lymphoproliferative disease in children: correlation of histology to clinical behavior . J Pediatr Hematol Oncol 2001 ; 23 : 1418 .
  • 25
    Collaborative Transplant Study . Available at : http://www.ctstransplant.org . Accessed August 10, 2003 .
  • 26
    International Association of Cancer Registries . Parkin DM , Whelan SL , Ferlay J , Teppo L , Thomas DB , eds . Cancer Incidence in Five Continents , Vol. VIII . Lyons , France : IARC Press , 2002 .
  • 27
    Fleiss JL . Statistical Methods for Rates and Proportions , 2nd edn . New York : Wiley , 1981 .
  • 28
    Leblond V , Sutton L , Darent R et al. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center . J Clin Oncol 1995 ; 13 : 961968 .
  • 29
    Leblond V , Davi F , Charlotte F et al. Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus; a distinct entity ? J Clin Oncol 1998 ; 16 : 20522059 .
  • 30
    Maisonneuve P , Asgodoa L , Gllert R et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study . Lancet 1999 ; 354 : 9399 .
  • 31
    Birkeland SA , Lokkegaard H , Storm HH . Cancr risk in patients on dialysis and after renal transplantation . Lancet 2000 ; 355 : 18861887 .
  • 32
    Preiksaitis JK , Keay S . Diagnosis and management of posttransplant lymphoproliferative disorder in solid transplant recipients . Clin Infect Dis 2001 ; 33 : S38S46 .
  • 33
    Pirsch JD , Miller J , Deierhoi MH , Vincenti F , Filo R for the FK506 Kidney Transplant Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation . Transplantation 1997 ; 63 : 977983 .
  • 34
    Weisner RH . A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the US FK506 Study Group . Transplantation 1998 ; 66 : 493499 .
  • 35
    Younes BS , McDiarmid SV , Martin MG et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant recipients . Transplantation 2000 ; 70 : 9499 .
  • 36
    Cockfield SM . Identifying the patients at risk for post-transplant lymphoproliferative disorder . Transplant Infect Dis 2001 ; 3 : 7078 .
  • 37
    Opelz G . Are post-transplant lymphomas inevitable ? Nephrol Dial Transpl 1996 ; 11 : 19521955 .
  • 38
    Jain A , Nalesnik M , Reyes J et al. Posttransplant lymphoproliferative disorders in liver transplantation . Ann Surg 2002 ; 236 : 429437 .
  • 39
    Tsai D , Hardy CL , Tomaszewski JE et al. Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients . Transplantation 2001 ; 71 : 10761088 .
  • 40
    Kew CE , 2nd Lopez-Ben R , Smith JK et al. Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation . Transplantation 2000 ; 69 : 809814 .